As liver steatosis in HFD-treated mice is CD36-dependent38, the elafin-driven reduction of hepatic Cd36 mRNA expression should mediate the inhibition of liver steatosis (Figure S6A). The gene discussed is PI3; the disease is Hepatic steatosis.